These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 32408657)

  • 1. Virtual Screening and the In Vitro Assessment of the Antileishmanial Activity of Lignans.
    Maia MDS; Silva JPRE; Nunes TAL; Sousa JMS; Rodrigues GCS; Monteiro AFM; Tavares JF; Rodrigues KADF; Mendonça-Junior FJB; Scotti L; Scotti MT
    Molecules; 2020 May; 25(10):. PubMed ID: 32408657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unveiling six potent and highly selective antileishmanial agents via the open source compound collection 'Pathogen Box' against antimony-sensitive and -resistant Leishmania braziliensis.
    Souza Silva JA; Tunes LG; Coimbra RS; Ascher DB; Pires DEV; Monte-Neto RL
    Biomed Pharmacother; 2021 Jan; 133():111049. PubMed ID: 33378956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights about resveratrol analogs against trypanothione reductase of
    da Silva AD; Dos Santos JA; Machado PA; Alves LA; Laque LC; de Souza VC; Coimbra ES; Capriles PVSZ
    J Biomol Struct Dyn; 2019 Jul; 37(11):2960-2969. PubMed ID: 30058445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antileismanial activity, mechanism of action study and molecular docking of 1,4-bis(substituted benzalhydrazino)phthalazines.
    Romero AH; Rodríguez N; Oviedo H; Lopez SE
    Arch Pharm (Weinheim); 2019 Jun; 352(6):e1800299. PubMed ID: 31012160
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Rebouças-Silva J; Santos GF; Filho JMB; Berretta AA; Marquele-Oliveira F; Borges VM
    Front Cell Infect Microbiol; 2022; 12():1045732. PubMed ID: 36704104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-based virtual screening, molecular docking, ADMET and molecular simulations to develop benzoxaborole analogs as potential inhibitor against Leishmania donovani trypanothione reductase.
    Pandey RK; Kumbhar BV; Sundar S; Kunwar A; Prajapati VK
    J Recept Signal Transduct Res; 2017 Feb; 37(1):60-70. PubMed ID: 27147242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 7-Chloro-4-quinolinyl hydrazones: a promising and potent class of antileishmanial compounds.
    Coimbra ES; Antinarelli LM; da Silva AD; Bispo ML; Kaiser CR; de Souza MV
    Chem Biol Drug Des; 2013 May; 81(5):658-65. PubMed ID: 23350797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of new N-benzyl-1H-benzimidazol-2-amine derivatives against cutaneous, mucocutaneous and visceral Leishmania species.
    Nieto-Meneses R; Castillo R; Hernández-Campos A; Maldonado-Rangel A; Matius-Ruiz JB; Trejo-Soto PJ; Nogueda-Torres B; Dea-Ayuela MA; Bolás-Fernández F; Méndez-Cuesta C; Yépez-Mulia L
    Exp Parasitol; 2018 Jan; 184():82-89. PubMed ID: 29191699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure based medicinal chemistry-driven strategy to design substituted dihydropyrimidines as potential antileishmanial agents.
    Rashid U; Sultana R; Shaheen N; Hassan SF; Yaqoob F; Ahmad MJ; Iftikhar F; Sultana N; Asghar S; Yasinzai M; Ansari FL; Qureshi NA
    Eur J Med Chem; 2016 Jun; 115():230-44. PubMed ID: 27017551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The alkylaminoalkanethiosulfuric acids exhibit in-vitro antileishmanial activity against Leishmania (Viannia) braziliensis: a new perspective for use of these schistosomicidal agents.
    Porcino GN; Antinarelli LMR; Maia ACRG; Faria-Pinto P; Taunay-Rodrigues A; Zech Coelho PM; Nelson DL; Penido MLO; Coimbra ES; Vasconcelos EG
    J Pharm Pharmacol; 2019 Dec; 71(12):1784-1791. PubMed ID: 31579947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and antitrypanosomatid activities of 3,5-diaryl-isoxazole analogues based on neolignans veraguensin, grandisin and machilin G.
    Trefzger OS; das Neves AR; Barbosa NV; Carvalho DB; Pereira IC; Perdomo RT; Matos MFC; Yoshida NC; Kato MJ; de Albuquerque S; Arruda CCP; Baroni ACM
    Chem Biol Drug Des; 2019 Mar; 93(3):313-324. PubMed ID: 30354012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, structure-activity relationship and mechanism of action studies of a series of 4-chloro-1-phthalazinyl hydrazones as a potent agent against Leishmania braziliensis.
    Romero AH; Medina R; Alcala A; García-Marchan Y; Núñez-Duran J; Leañez J; Mijoba A; Ciangherotti C; Serrano-Martín X; López SE
    Eur J Med Chem; 2017 Feb; 127():606-620. PubMed ID: 28119201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antifungal compound butenafine eliminates promastigote and amastigote forms of Leishmania (Leishmania) amazonensis and Leishmania (Viannia) braziliensis.
    Bezerra-Souza A; Yamamoto ES; Laurenti MD; Ribeiro SP; Passero LF
    Parasitol Int; 2016 Dec; 65(6 Pt A):702-707. PubMed ID: 27546158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L-Asparaginase as a new molecular target against leishmaniasis: insights into the mechanism of action and structure-based inhibitor design.
    Singh J; Srivastava A; Jha P; Sinha KK; Kundu B
    Mol Biosyst; 2015 Jul; 11(7):1887-96. PubMed ID: 25893895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antileishmanial activity of azithromycin against Leishmania (Leishmania) amazonensis, Leishmania (Viannia) braziliensis, and Leishmania (Leishmania) chagasi.
    de Oliveira-Silva F; de Morais-Teixeira E; Rabello A
    Am J Trop Med Hyg; 2008 May; 78(5):745-9. PubMed ID: 18458308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraspecies susceptibility of Leishmania (Viannia) braziliensis to antileishmanial drugs: Antimony resistance in human isolates from atypical lesions.
    Rugani JN; Quaresma PF; Gontijo CF; Soares RP; Monte-Neto RL
    Biomed Pharmacother; 2018 Dec; 108():1170-1180. PubMed ID: 30372818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leishmania tarentolae: utility as an in vitro model for screening of antileishmanial agents.
    Taylor VM; Muñoz DL; Cedeño DL; Vélez ID; Jones MA; Robledo SM
    Exp Parasitol; 2010 Dec; 126(4):471-5. PubMed ID: 20685203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antileishmanial activity, cytotoxicity and QSAR analysis of synthetic dihydrobenzofuran lignans and related benzofurans.
    Van Miert S; Van Dyck S; Schmidt TJ; Brun R; Vlietinck A; Lemière G; Pieters L
    Bioorg Med Chem; 2005 Feb; 13(3):661-9. PubMed ID: 15653333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leishmanicidal activity of synthetic chalcones in Leishmania (Viannia) braziliensis.
    de Mello TF; Bitencourt HR; Pedroso RB; Aristides SM; Lonardoni MV; Silveira TG
    Exp Parasitol; 2014 Jan; 136():27-34. PubMed ID: 24269198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antileishmanial activity of lapachol analogues.
    Lima NM; Correia CS; Leon LL; Machado GM; Madeira Mde F; Santana AE; Goulart MO
    Mem Inst Oswaldo Cruz; 2004 Nov; 99(7):757-61. PubMed ID: 15654435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.